Australian Clinical Labs Ltd. provides pathology testing for both routine and advanced conditions. Its services include routine pathology, genetic testing, first-trimester screening, non-invasive prenatal testing, hematology, immunology, and functional pathology. Its locations span Victoria, New South Wales, Western Australia, South Australia, and Queensland. Read on to find out how this company can help your health. This is an article from Healthdirect.
Table of Contents
Healthdirect at Australian Clinical Labs
The challenges Healthdirect Australia faced were not limited to regulatory pressures and data access. Multiple data silos, disjointed data sources, and an inefficient architecture created significant operational overhead. Healthdirect Australia sought to improve patient access to health information with a cloud-based platform. The Healthdirect Australia team chose a platform called Databricks that would meet their requirements while improving data quality and security. Ultimately, the team was able to implement a better experience for people seeking health information.
The Healthdirect Australia website has a comprehensive list of health tests and services. The health care call center offers telephone-based triage and advice. The data for this project are linked to routinely collected data such as emergency department and hospital admissions, mortality data, and the 45 and Up Study baseline questionnaire. It will look at the extent to which advice is followed, and identify characteristics of patients who follow advice less than others. It will also look at service delivery features to improve the patient experience.
The data obtained from Healthdirect’s databases showed that most of the patients self-referred were unidentified and presented with an injury. Patients who self-referred also had higher rates of toxicological and psychiatric presentations. There were 186 patients whose healthdirect records did not allow them to be traced, and these cases were categorized as ‘unknown’. These results may be a result of incomplete demographic data or anonymous callers.
Another study also found that patients who self-referred to Healthdirect were significantly younger than other patient groups. Healthdirect patients were more likely to be female, self-referred, and present during out-of-hours hours. The acuity profile for self-referred patients was higher than those of GP-referred patients. However, the average length of stay was shorter for these healthcare consumers. Further, the patients were referred to healthdirect clinics despite their lack of health insurance.
Dr. Deam’s career
The Australian Clinical Labs Limited (ACLL) is a privately owned pathology company in Australia. The laboratory performs a wide range of pathology tests on behalf of clients. The ACLU has laboratories in all Australian states, except Tasmania. It is listed on the Australian Securities Exchange (ASX) under the symbol ACL. The ACLL employs approximately 2794 people. As a pathology laboratory, ACLL provides testing for infectious diseases, cardiovascular disease, gastroenterology, and thyroid function.
Dr. Deam’s career at Australian Clinical Labs
Dr. Deam has worked as a pathologist at Australian Clinical Labs since 1998. He obtained his undergraduate degree from Monash University in 1978 and his FRCPA in 1985. He then undertook postgraduate training in biochemistry at the Royal Melbourne Hospital. He later held posts in chemical pathology at the Royal Women’s Hospital and Royal Melbourne Hospital. He was appointed Head of Chemical Pathology at the Royal Melbourne Hospital in 1996 and then joined Gribbles Pathology (now Australian Clinical Labs). Dr Deam has been active in teaching his scientific staff and has been an examiner for the Australasian Association of Clinical Biochemists.
Value of clinical laboratories in the healthcare system
The role of clinical laboratories in the Australian healthcare system is immense. In one typical day, these facilities conduct testing for approximately 530,000 patients. The data that these facilities collect is valuable for improving the health of individuals and the entire population, particularly in communities where access to healthcare is limited or non-existent. This information can then help to improve patient care and ultimately reduce costs. But how do we achieve these benefits? We must work with labs and providers to develop integrated solutions that can make the data available more quickly and easily to the entire healthcare system.
A more thorough economic analysis is needed to understand the real value of laboratory services. It is necessary to look beyond cost-benefit analysis to include more complex factors, such as patient outcomes. While the final goal of all laboratory tests is to improve patient outcomes, the final aim of these tests is to influence treatment decisions. With this in mind, healthcare systems worldwide are moving toward models that measure the value of laboratory information in enhancing the effectiveness of care.
While the value of clinical laboratories in the Australian healthcare system is not as high as that of physician care, it cannot be understated. Clinical laboratories play an important role in stratifying risk, identifying care gaps, and improving overall health outcomes. They also contribute to the reduction of health disparities, modifying determinants of health, and highlighting individual patient risks and care needs. These capabilities enable clinical partners to improve patient care and achieve higher levels of performance.
However, the sale of clinical laboratories is not without risk. Moreover, organizations that outsource laboratory operations risk giving up control of an irreplaceable information asset that is critical for clinical diagnosis, treatment, and research. With such a shift, many hospitals have concluded that selling their laboratories is the best path forward to reduce expenses and increase cash infusion. This allows them to improve patient care by reducing overutilization.
Australian clinical laboratories are the largest provider of pathology services in Australia. With over 89 NATA-accredited laboratories across the country, they perform close to six million episodes per year for a variety of clients. To learn more about the services provided by these laboratories, click here. Listed below are some of their key services. They provide a range of diagnostic tests, including blood grouping, serology, and microbiology.
Sonic Healthcare is the largest pathology provider in Australia, with a network of collection centers and state-of-the-art laboratories. These clinics serve all Australian capital cities and regional and rural communities. They are among Australia’s largest healthcare providers, with a commitment to medical leadership and excellent patient care. The company has since expanded its operations overseas, becoming the third-largest private laboratory company in the US. Sonic has locations throughout Australia and New Zealand.
ULTRA LIS is an enterprise information system from Cirdan. The system supports virtual environments, providing greater disaster recovery and failover resilience. Users can seamlessly migrate data from one lab to another without the need to restart the entire network. Clinical Labs recently upgraded their ULTRA LIS to support virtual environments. The upgrade improved the functionality and stability of pathology workflows. With Cirdan’s help, they are building a virtual laboratory environment that can be easily relocated.
The Australian Clinical Labs’ financial return is not looking good, but the firm has been able to justify these payments. It has increased profits by 44 percent since the pandemic started and has a profit margin of $100 million. It is one of the three pathology laboratories that are sharing at least $1.6 billion from the Morrison government for COVID-19 testing since March 2020. Last year’s revenue grew by 29 percent.
For More Articles Visit: Digital Combination